#batman#dc#dc comics#bruce wayne#tim drake#dc fanart#batfamily#dick grayson#batfam
seen from India
seen from India
seen from United States
seen from Thailand
seen from Brazil
seen from Thailand
seen from Malaysia
seen from United States
seen from China
seen from China
seen from Germany
seen from United States
seen from United States
seen from Canada
seen from United States
seen from United Kingdom
seen from United States
seen from Russia
seen from United States
seen from Yemen
Soligenix BioDefense business segment includes active development programs for RiVax®, its ricin toxin vaccine candidate, OrbeShield®
Analyst Activity – Maxim Group Raises Its Price Target On Soligenix (OTC:SNGX) to $4.00
Analyst Activity – Maxim Group Raises Its Price Target On Soligenix (OTC:SNGX) to $4.00
Analyst Ratings For Soligenix (OTC:SNGX) Today, Maxim Group raised its price target on Soligenix (OTC:SNGX) to $4.00 per share. There are 1 buy rating on the stock. The current consensus rating on Soligenix (OTC:SNGX) is Buy (Score: 3.00) with a consensus target price of $4.00 per share, a potential . Some recent analyst ratings include Dividend information for Soligenix (OTC:SNGX) . About…
View On WordPress
Analyst Activity – Maxim Group Raises Its Price Target On Soligenix (OTCBB:SNGX) to $4.00
Analyst Activity – Maxim Group Raises Its Price Target On Soligenix (OTCBB:SNGX) to $4.00
Analyst Ratings For Soligenix (OTCBB:SNGX) Today, Maxim Group raised its price target on Soligenix (OTCBB:SNGX) to $4.00 per share. There are 2 buy ratings on the stock. The current consensus rating on Soligenix (OTCBB:SNGX) is Buy (Score: 3.00) with a consensus target price of $5.00 per share, a potential . Some recent analyst ratings include 9/7/2016-Aegis initiated coverage with a Buy rating.…
View On WordPress
